Figures & data
Figure 1 S100A16, E-cadherin, and vimentin expression in lung adenocarcinoma. (A) The majority of the tumor cells showed membranous S100A16 expression (arrows) in lung adenocarcinoma (×400 magnification). (B) Membranous staining of the tumor cells (arrows) was considered to be a positive result for E-cadherin (arrow, ×200 magnification). (C) Cytoplasmic staining of the tumor cells (arrow heads) was considered to be a positive result for vimentin (×200 magnification).
![Figure 1 S100A16, E-cadherin, and vimentin expression in lung adenocarcinoma. (A) The majority of the tumor cells showed membranous S100A16 expression (arrows) in lung adenocarcinoma (×400 magnification). (B) Membranous staining of the tumor cells (arrows) was considered to be a positive result for E-cadherin (arrow, ×200 magnification). (C) Cytoplasmic staining of the tumor cells (arrow heads) was considered to be a positive result for vimentin (×200 magnification).](/cms/asset/6f7c048a-788c-421c-a3af-34436933b4bd/dott_a_12195678_f0001_c.jpg)
Table 1 Characteristics of the patients
Table 2 Relationships between S100A16 expression and clinic-opathological parameters
Figure 2 Survival analysis. (A) DFS; (B) OS.
![Figure 2 Survival analysis. (A) DFS; (B) OS.](/cms/asset/5bb46924-842e-4b36-bdf4-c0a1bee5d46c/dott_a_12195678_f0002_c.jpg)
Table 3 Univariable and multivariable analyses of the effects of S100A16 expression on OS
Table 4 Relationships between S100A16 expression and EMT markers E-cadherin and vimentin